Compass Pathways Psilocybin Patent Upheld

Compass Pathways Psilocybin Patent Upheld

Psychedelic Spotlight reports Compass Pathways scores a major victory in their bid to patent Comp 360, a proprietary formulation of psilocybin. Ever since Compass Pathways (Nasdaq: CMPS) first entered the public eye, there has been a debate raging on whether their version of psilocybin, Comp 360, is deserving of a patent. The crux of the debate came down to whether Comp 360 is a unique compound that has never been created before, or whether the synthetic psilocybin had previously existed in the public domain. Now it seems —at least in the eyes of the law— this debate has been settled, and Compass Pathways has emerged victorious Previously, Compass had been granted two patents covering Comp 360 —also known as Polymorph A— but these were being challenged by a group called Freedom to Operate. Essentially, Freedom to Operate petitioned the Patent Trial and Appeal Board (PTAB), claiming that Comp 360 was not a novel invention, and thus should have its patents revoked. If the Patent Trial and Appeal Board, having seen the evidence provided by Freedom to Operate, had agreed that there was at least some validity to the evidence, the case would have gone to trial. However, that is not what happened. On June 23rd, 2022, the Patent Trial and Appeal Board announced that it agreed with Compass’ interpretation of its patents, meaning it would not go to trial. There is no right to appeal this decision, making it final. A large part of the rationale behind the Board’s decision, is that Comp 360 has a unique chemical shape, as determined by an x-ray powder diffraction (XRPD) diffractogram. Despite this victory, the Compass Pathways psilocybin patent saga isn’t necessarily over. Speaking with Vice’s Shayla Love, Jack Griem, a lawyer for Freedom to Operate, argued that since the Patent Trial and Appeal Board defined Comp 360…

Excerpt only …
Source : Compass Pathways Psilocybin Patent Upheld

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.